X
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ATAZANAVIR SULPHATE, with a corresponding US DMF Number 21967.
Remarkably, this DMF maintains an Active status since its submission on March 26, 2009, highlighting commitment to regulatory compliance.